Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Gonorrhea Therapeutics Market 2017-2021 - Key Vendors are Bharat Pharmaceuticals, GlaxoSmithKline, Merck & Pfizer - Research and Markets

Research and Markets
Posted on: 03 Nov 17

The "Global Gonorrhea Therapeutics Market 2017-2021" report has been added to Research and Markets' offering.

The global gonorrhea therapeutics market to grow at a CAGR of 2.88% during the period 2017-2021.

Global Gonorrhea Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. As the market has a deep penetration of generics, the growth rate is expected to be moderate during the forecast period. Additionally, the advent of new antibiotic-resistant strains will continue to hinder the growth prospects.

The latest trend gaining momentum in the market is Advent of vaccine for prevention of gonorrhea . Gonorrhea is a major public health concern globally. It is considerably affecting the reproductive health of people and increasing the spread of human immunodeficiency virus (HIV). The currently available treatment regimen is unsuccessful in controlling the spread of Neisseria gonorrhoeae due to the rapid emergence of the antibiotic-resistant strains of this bacterium. Therefore, the prevention of the disease seems to be a more appropriate approach for controlling the spread of Neisseria gonorrhoeae.

According to the report, one of the major drivers for this market is Rising prevalence of disease. The rising prevalence of gonorrhea is a major health concern globally. The disease follows chlamydial infection as the second most common STD in the US. The rising prevalence rate of gonorrhea is due to several factors such as growing awareness, increased healthcare access, availability of diagnostic tests, resistance patterns, reporting practices, and the financial constraints that limit the abilities of public healthcare officials to check the disease pattern precisely.

Further, the report states that one of the major factors hindering the growth of this market is Emergence of antibiotic-resistant gonococcal strain. The global gonorrhea therapeutics market is familiar with antibiotic resistance in gonorrheal strains. In 2007, the emergence of fluoroquinolone-resistant Neisseria gonorrhoeae prompted the CDC to prohibit the use of fluoroquinolone in the US, leaving cephalosporin as the only treatment option for gonorrheal infection.

Key vendors

  • Bharat Pharmaceuticals
  • GlaxoSmithKline
  • Merck
  • Pfizer

Other prominent vendors

  • Alopexx Pharmaceuticals
  • AstraZeneca
  • Cempra
  • Debiopharm Group
  • Melinta Therapeutics

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Gonorrhea: A Brief Introduction

Part 06: Market Landscape

Part 07: Pipeline

Part 08: Market Segmentation By Application

Part 09: Regional Landscape

Part 10: Decision Framework

Part 11: Drivers And Challenges

Part 12: Market Trends

Part 13: Vendor Landscape

Part 14: Key Vendor Analysis

Part 15: Appendix

For more information about this report visit

View source version on

Business Wire

Last updated on: 03/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.